Additional file 1: Table S1. Summary of whole exome sequencing data quality control for patient-derived biopsies and xenografts (paired-end read length 2âĂâ150 bp for all samples)
Table S1. RNA-sequencing results for tumor tissue (a) or non-malignant lung tissue (b). Differential...
Table S1. Sequencing metrics for libraries prepared with both Agilent SureSelect XT v.5 and Roche Ni...
Genes of interest previously reported in MM and primer sequences used to detect expression of the ta...
Additional file 1: Table S1. Quality control metrics of targeted sequencing data. Table S2. Quality ...
Additional file 1: Table S1. Clinical information of PDXs used for TIL studies. Table S2. Clinical i...
Table S7. Mean coverage achieved by Agilent SureSelect and Roche NimbleGen libraries within 90 PCR-c...
Table S1. Clinical and biological data of the patients included in the study. Table S2. Tagmented DN...
Table S2. Pathology estimate and SNVs of eight PDX samples. Percentage of mouse stromal cells, detec...
Table S1. WGS of mouse strains mapped to human. Number of sequence reads from 3 mouse strains mapped...
Figure S1. Performance of XenofilteR and Xenome on PDX samples. Mutation calling and read counts for...
Additional file 1: Figure S1. Workflow of data processing and bioinformatics pipeline for whole-exom...
List of top 100 proteins that are often identified in exosomes (ExoCarta). (PDF 158 kb
Table S1. Clinical characteristics of the patientsâ cohort. Samples from 42 patients were availabl...
Supplementary tables. Table S1. Cancer genes in detected amplification regions. Table S2. Cancer gen...
Table S1. Sequencing parameters for 3 samples with the highest and 3 samples with the lowest sequenc...
Table S1. RNA-sequencing results for tumor tissue (a) or non-malignant lung tissue (b). Differential...
Table S1. Sequencing metrics for libraries prepared with both Agilent SureSelect XT v.5 and Roche Ni...
Genes of interest previously reported in MM and primer sequences used to detect expression of the ta...
Additional file 1: Table S1. Quality control metrics of targeted sequencing data. Table S2. Quality ...
Additional file 1: Table S1. Clinical information of PDXs used for TIL studies. Table S2. Clinical i...
Table S7. Mean coverage achieved by Agilent SureSelect and Roche NimbleGen libraries within 90 PCR-c...
Table S1. Clinical and biological data of the patients included in the study. Table S2. Tagmented DN...
Table S2. Pathology estimate and SNVs of eight PDX samples. Percentage of mouse stromal cells, detec...
Table S1. WGS of mouse strains mapped to human. Number of sequence reads from 3 mouse strains mapped...
Figure S1. Performance of XenofilteR and Xenome on PDX samples. Mutation calling and read counts for...
Additional file 1: Figure S1. Workflow of data processing and bioinformatics pipeline for whole-exom...
List of top 100 proteins that are often identified in exosomes (ExoCarta). (PDF 158 kb
Table S1. Clinical characteristics of the patientsâ cohort. Samples from 42 patients were availabl...
Supplementary tables. Table S1. Cancer genes in detected amplification regions. Table S2. Cancer gen...
Table S1. Sequencing parameters for 3 samples with the highest and 3 samples with the lowest sequenc...
Table S1. RNA-sequencing results for tumor tissue (a) or non-malignant lung tissue (b). Differential...
Table S1. Sequencing metrics for libraries prepared with both Agilent SureSelect XT v.5 and Roche Ni...
Genes of interest previously reported in MM and primer sequences used to detect expression of the ta...